Exemestane
Back to searchMolecule Structure
Scientific Name
Exemestane
Description of the Drug
Exemestane is an aromatase inhibitor used to treat breast cancer in postmenopausal women after treatment with tamoxifen.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00990
http://www.drugbank.ca/drugs/DB00990
Brand Name(s)
Aromasin, Exemestane
Company Owner(s)
Cipla Ltd, Breckenridge Pharmaceutical Inc, Qilu Pharmaceutical Co Ltd, Alvogen Inc, Mayne Pharma Inc, Upsher Smith Laboratories Llc, Eugia Pharma Specialities Ltd, Amneal Pharmaceuticals Of New York Llc, Zydus Pharmaceuticals Usa Inc, Hikma Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cytochrome P450 19A1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1978 |
Clinical Trial(s)
Unichem Links
Atlas | exemestane | |
SureChEMBL | SCHEMBL6215 | |
PharmGKB | PA449563 | |
Human Metabolome Database | HMDB0015125 | |
DrugBank | DB00990 | |
PubChem: Thomson Pharma | 14922734 | 14898201 |
PubChem | 60198 | |
LINCS | LSM-5474 | |
Nikkaji | J367.471A | |
PDBe | EXM | |
BindingDB | 50398447 | |
EPA CompTox Dashboard | DTXSID5023037 | |
DrugCentral | 1122 | |
ChemicalBook | CB5760314 | |
Guide to Pharmacology | 7073 | |
rxnorm | EXEMESTANE | AROMASIN |
PubChem: Drugs of the Future | 12014009 | |
ChEBI | 4953 | |
ZINC | ZINC000003973334 |